COUPANG INC (CPNG)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-09-15
$14.68-2.85%
Close 2026-09-15 · 1-day change
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-09-15
Research Workspace
Put CPNG beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is slowing — up about 10% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 35%, softest on returns on capital.
View QualityManagement screens weak on capital allocation, earnings delivery, margins, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 56% in its worst 12-month stretch.
View RiskCoupang's growth in the Product Commerce segment must continue to justify its price. Revenue grew 4% year over year, and the last quarter beat expectations by 65%. It trades at 0.8× price-to-sales versus a peer median of 0.8×. The price reflects less growth than forecast, indicating modest expectations. Specific risks include regulatory scrutiny and softer guidance impacting profitability. Peer multiples imply a price about 11% above where it trades. Our read remains intact; this read is provisional.
Trailing returns as of 2026-09-15. CPNG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering CPNG (as of Sep 2026).
Based on 6 Wall Street analysts offering 12-month price targets for CPNG in the last 4 months.
Continue this research
Compare CPNG with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CPNG Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-09-15. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Broadline Retail — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CPNG next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Regulatory risks may hinder growth potential.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
Current $14.68
The last 12 months of price, then the range of analyst 12-month targets from today’s $14.68.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Threatens: Improve overall profitability and reduce operating losses
Softer guidance indicates potential profitability issues.
Regulatory scrutiny could hinder growth and profitability objectives.
Legal issues could hinder growth and profitability objectives.
Advances: Grow Product Commerce segment revenue and customer base
Significant revenue growth supports product commerce objectives.
Threatens: Address regulatory challenges
Significant fine impacts regulatory standing and profitability.
Threatens: Address regulatory challenges
Record fine exacerbates regulatory challenges and profitability issues.
Advances: Improve profitability
Fee-free service could enhance profitability and customer growth.